A nurse is caring for a client who is being evaluated for ovarian hyperstimulation syndrome (OHSS). Which of the following factors should the nurse identify as a potential cause of the client's condition?

Choice A rationale

Choice A rationale:

Systemic hypertension is not a primary contraindication for the initiation of post-exposure prophylaxis medications. While specific antiviral agents might require monitoring of renal or hepatic function, which can be influenced by long-term poorly controlled blood pressure, the immediate need to prevent viral replication takes precedence. Patients with high blood pressure can safely undergo the 28-day regimen provided their clinical status is monitored by a healthcare provider for any drug-to-drug interactions with existing antihypertensives.

Choice B rationale

Choice B rationale:

The efficacy of post-exposure prophylaxis is highly time-dependent, as it must be initiated as soon as possible after a potential exposure to human immunodeficiency virus. Waiting up to 2 weeks would render the treatment ineffective because the virus would have already integrated into the host genome and established a permanent infection. Clinical guidelines strongly recommend starting the medication within 72 hours of exposure to maximize the chance of preventing viral replication and systemic spread.

Choice C rationale

Choice C rationale:

Effectiveness of post-exposure prophylaxis depends on strict adherence to the prescribed dosing schedule for a full 28-day duration. This timeframe is scientifically based on the period required to ensure that any virus introduced into the body is unable to complete its replication cycle and establish a reservoir. Skipping doses or ending the treatment early significantly increases the risk of seroconversion, allowing the virus to become a chronic infection despite the initial preventative efforts.

Choice D rationale

Choice D rationale:

Percutaneous exposure, such as a needle stick injury involving contaminated blood, represents a significant transmission risk for human immunodeficiency virus. The virus can be directly introduced into the bloodstream through the puncture site, bypassing the body's primary skin barriers. Therefore, a needle stick exposure is a primary indication for starting a post-exposure prophylaxis regimen immediately to reduce the probability of the virus becoming established within the lymphatic system and the rest of the body.

Choice A rationale

Clomiphene and letrozole are medications primarily used in the treatment of infertility rather than pregnancy termination. Clomiphene is a selective estrogen receptor modulator that induces ovulation by stimulating the release of gonadotropins. Letrozole is an aromatase inhibitor that similarly promotes ovulation. Neither of these drugs possesses the pharmacological properties required to interrupt an established pregnancy or induce the uterine contractions necessary for a medical abortion procedure in the first trimester.

Choice B rationale

Methotrexate and vincristine are potent cytotoxic chemotherapy agents. While methotrexate is occasionally used off-label to treat ectopic pregnancies by inhibiting rapidly dividing fetal cells, it is not the standard primary protocol for a planned medical abortion at nine weeks. Vincristine is used to treat various malignancies and has no role in elective pregnancy termination. The combination of these two drugs is inappropriate for the client's requested procedure and would pose unnecessary systemic toxicity.

Choice C rationale

This is the evidence-based pharmacological combination for medical abortion up to 10 or 11 weeks of gestation. Mifepristone acts as a progesterone antagonist, blocking the hormone necessary to maintain the uterine lining and pregnancy. Misoprostol, a prostaglandin E1 analogue, is administered subsequently to induce cervical softening and uterine contractions, leading to the expulsion of the products of conception. This regimen is highly effective and widely accepted as the gold standard in reproductive medicine.

Choice D rationale

Dinoprostone and oxytocin are typically reserved for cervical ripening and the induction of labor in the second or third trimesters. Dinoprostone is a prostaglandin used to prepare the cervix, while oxytocin stimulates powerful uterine contractions to facilitate vaginal delivery. These medications are not used for medical abortions at nine weeks of gestation because the uterus is not yet sensitive enough to oxytocin, and more effective oral or vaginal options like misoprostol exist.